Skip to main content
NCBI home page
The Journal of the Royal College of General Practitioners logoLink to The Journal of the Royal College of General Practitioners
. 1970 Nov;20(100):269–277.

Essential hypertension and its treatment by the family physician. A study of sixty-one cases.

M H Coigley
PMCID: PMC2237384  PMID: 5492617

Full text

PDF
269

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEIN H. J. Zur Pharmakologie des Reserpin, eines neuen Alkaloids aus Rauwolfia serpentina Benth. Experientia. 1953 Mar 15;9(3):107–110. doi: 10.1007/BF02178342. [DOI] [PubMed] [Google Scholar]
  2. Bath J., Pickering D., Turner R. Clinical experience with bethanidine in treatment of hypertension. Br Med J. 1967 Dec 2;4(5578):519–521. doi: 10.1136/bmj.4.5578.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. FREIS E. D., ARI R. Clinical and experimental effects of reserpine in patients with essential hypertension. Ann N Y Acad Sci. 1954 Apr 30;59(1):45–53. doi: 10.1111/j.1749-6632.1954.tb45917.x. [DOI] [PubMed] [Google Scholar]
  4. GRIEBLE H. G., JOHNSTON L. C. Treatment of arterial hypertensive disease with diuretics. I. Effects on blood pressure of bendroflumethiazide, potassium chloride, and spironolactone. Arch Intern Med. 1962 Jul;110:26–33. doi: 10.1001/archinte.1962.03620190028004. [DOI] [PubMed] [Google Scholar]
  5. HAMILTON M., THOMPSON E. M., WISNIEWSKI T. K. THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION. Lancet. 1964 Feb 1;1(7327):235–238. doi: 10.1016/s0140-6736(64)92344-x. [DOI] [PubMed] [Google Scholar]
  6. HARRIS R. Clinical use of reserpine (serpasil) in geriatrics. Ann N Y Acad Sci. 1954 Apr 30;59(1):95–106. doi: 10.1111/j.1749-6632.1954.tb45921.x. [DOI] [PubMed] [Google Scholar]
  7. KOBINGER W., KATIC U. [The pharmacological properties of benzylhydroflumethiazide, a new orally effective diuretic]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1960;238:435–453. [PubMed] [Google Scholar]
  8. LEISHMAN A. W. Hypertension: treated and untreated; a study of 400 cases. Br Med J. 1959 May 30;1(5134):1361–1368. doi: 10.1136/bmj.1.5134.1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MARSHALL J. A TRIAL OF LONG-TERM HYPOTENSIVE THERAPY IN CEREBROVASCULAR DISEASE. Lancet. 1964 Jan 4;1(7323):10–12. doi: 10.1016/s0140-6736(64)92157-9. [DOI] [PubMed] [Google Scholar]
  10. McQUEEN E. G., DOYLE A. E., SMIRK F. H. The circulatory effects of reserpine. Circulation. 1955 Feb;11(2):161–169. doi: 10.1161/01.cir.11.2.161. [DOI] [PubMed] [Google Scholar]
  11. PLATT R. THE NATURAL HISTORY AND EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION. Practitioner. 1964 Jul;193:5–13. [PubMed] [Google Scholar]
  12. PLUMMER A. J., EARL A., SCHNEIDER J. A., TRAPOLD J., BARRETT W. Pharmacology of Rauwolfia alkaloids, including reserpine. Ann N Y Acad Sci. 1954 Apr 30;59(1):8–21. doi: 10.1111/j.1749-6632.1954.tb45914.x. [DOI] [PubMed] [Google Scholar]
  13. Porter A. M. Drug defaulting in a general practice. Br Med J. 1969 Jan 25;1(5638):218–222. doi: 10.1136/bmj.1.5638.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Prichard B. N. Hypotensive drugs. Practitioner. 1968 Jan;200(195):30–38. [PubMed] [Google Scholar]
  15. RICHARDSON D. W., HONOUR A. J., FENTON G. W., STOTT F. H., PICKERING G. W. VARIATION IN ARTERIAL PRESSURE THROUGHOUT THE DAY AND NIGHT. Clin Sci. 1964 Jun;26:445–460. [PubMed] [Google Scholar]
  16. SCHLITTLER E., MACPHILLAMY H. B., DORFMAN L., FURLENMEIER A., HUEBNER C. F., LUCAS R., MUELLER J. M., SCHWYZER R., ST. ANDRE A. F. Chemistry of Rauwolfia alkaloids, including reserpine. Ann N Y Acad Sci. 1954 Apr 30;59(1):1–7. doi: 10.1111/j.1749-6632.1954.tb45913.x. [DOI] [PubMed] [Google Scholar]
  17. TAPIA F. A., DUSTAN H. P., SCHNECKLOTH R. A., CORCORAN A. C., PAGE I. H. Enhanced effectiveness of ganglion-blocking agents in hypertensive patients during administration of a saluretic agent (chlorothiazide). Lancet. 1957 Oct 26;273(7000):831–833. doi: 10.1016/s0140-6736(57)91494-0. [DOI] [PubMed] [Google Scholar]
  18. VAKIL R. J. A clinical trial of Rauwolfia serpentina in essential hypertension. Br Heart J. 1949 Oct;11(4):350–355. doi: 10.1136/hrt.11.4.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. WILKINS R. W. Clinical usage of Rauwolfia alkaloids, including reserpine (serpasil). Ann N Y Acad Sci. 1954 Apr 30;59(1):36–44. doi: 10.1111/j.1749-6632.1954.tb45916.x. [DOI] [PubMed] [Google Scholar]
  20. WINSOR T. Human pharmacology of reserpine. Ann N Y Acad Sci. 1954 Apr 30;59(1):61–81. doi: 10.1111/j.1749-6632.1954.tb45919.x. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of the Royal College of General Practitioners are provided here courtesy of Royal College of General Practitioners

RESOURCES